Filters
reset allOther countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Invitae Expanded Renal Disease Panel Invitae United States | 693 | 388 |
|
THBD - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 323 | 329 |
|
Atypical Hemolytic Uremic Syndrome (aHUS) Panel Centogene AG - the Rare Disease Company Germany | 23 | 25 |
|
Centogene AG - the Rare Disease Company Germany | 110 | 112 |
|
Invitae Inborn Errors of Immunity and Cytopenias Panel Invitae United States | 755 | 562 |
|
Invitae Complement Deficiency Disorders Panel Invitae United States | 35 | 22 |
|
Invitae Atypical Hemolytic Uremic Syndrome and Thrombotic Microangiopathies Panel Invitae United States | 25 | 13 |
|
aHUS Genetic Panel (20 genes) (2 Day STAT TAT) Machaon Diagnostics United States | 7 | 17 |
|
Invitae Primary Immunodeficiency Panel Invitae United States | 552 | 424 |
|
Invitae Hereditary Thrombophilia Panel Invitae United States | 24 | 11 |
|
Molecular Otolaryngology and Renal Research Laboratories University of Iowa Hospital and Clinics United States | 21 | 15 |
|
PreventionGenetics United States | 78 | 79 |
|
Comprehensive Thrombotic Microangiopathy NGS Panel Fulgent Genetics United States | 58 | 37 |
|
Fulgent Genetics United States | 46 | 18 |
|
Comprehensive Primary Immunodeficiency NGS Panel Fulgent Genetics United States | 1048 | 472 |
|
Comprehensive Thrombosis, Platelet Disorder, and Coagulation Deficiency NGS Panel Fulgent Genetics United States | 146 | 82 |
|
Focus Thrombotic Microangiopathy NGS Panel Fulgent Genetics United States | 40 | 22 |
|
ATYPICAL HEMOLYTIC UREMIC SYNDROME Laboratorio de Genetica Clinica SL Spain | 7 | 7 |
|
THBD Deletion/duplication analysis Cincinnati Children's Hospital Medical Center Genetics and Genomics Diagnostic Laboratory Cincinnati Children's Hospital Medical Center United States | 2 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.